TruBridge, Inc. (TBRG)
NASDAQ: TBRG · Real-Time Price · USD
19.29
+0.08 (0.42%)
Nov 5, 2025, 4:00 PM EST - Market closed
TruBridge Market Cap
TruBridge has a market cap or net worth of $280.06 million as of November 6, 2025. Its market cap has increased by 45.26% in one year.
Market Cap
280.06M
Enterprise Value
436.62M
1-Year Change
45.26%
Ranking
Category
Stock Price
$19.29
Market Cap Chart
Since May 21, 2002, TruBridge's market cap has increased from $190.00M to $280.06M, an increase of 47.40%. That is a compound annual growth rate of 1.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 289.60M | -1.60% |
| Dec 31, 2024 | 294.30M | 80.66% |
| Dec 29, 2023 | 162.90M | -58.77% |
| Dec 30, 2022 | 395.10M | -7.95% |
| Dec 31, 2021 | 429.20M | 10.19% |
| Dec 31, 2020 | 389.50M | 2.77% |
| Dec 31, 2019 | 379.00M | 7.18% |
| Dec 31, 2018 | 353.60M | -14.47% |
| Dec 29, 2017 | 413.40M | 29.43% |
| Dec 30, 2016 | 319.40M | -43.20% |
| Dec 31, 2015 | 562.30M | -17.42% |
| Dec 31, 2014 | 680.90M | -1.28% |
| Dec 31, 2013 | 689.70M | 23.67% |
| Dec 31, 2012 | 557.70M | -1.36% |
| Dec 30, 2011 | 565.40M | 10.11% |
| Dec 31, 2010 | 513.50M | 1.62% |
| Dec 31, 2009 | 505.30M | 73.23% |
| Dec 31, 2008 | 291.70M | 18.63% |
| Dec 31, 2007 | 245.90M | -32.74% |
| Dec 29, 2006 | 365.60M | -16.81% |
| Dec 30, 2005 | 439.50M | 81.01% |
| Dec 31, 2004 | 242.80M | 15.07% |
| Dec 31, 2003 | 211.00M | -18.75% |
| Dec 31, 2002 | 259.70M | 36.68% |
| May 21, 2002 | 190.00M | - |
View and export this data all the way back to 2002. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 802.74B |
| Johnson & Johnson | 448.76B |
| AbbVie | 374.44B |
| UnitedHealth Group | 302.36B |
| AstraZeneca | 252.04B |
| Novartis AG | 236.44B |
| Novo Nordisk | 216.34B |
| Abbott Laboratories | 215.34B |